Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 215
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Completed
Not specified
Other
SMD/ATG-CSA/2002
NCT00488436
Last Modified:
11/1/1997
2.
Phase II/III Pilot Treatment of Pediatric Non-B, Non-T ALL in First Marrow Relapse (SIMAL #8): Intensive Re-Induction and Reconsolidation Chemotherapy with Subsequent Myeloablative Chemoradiotherapy and Rescue with Either Allogeneic or In Vitro-Purged Autologous Marrow (Summary Last Modified 11/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
under 21 at relapse
NCI
POG-9410
POG-SIMAL-8
Last Modified:
7/11/2007
 
First Published:
4/1/1998
3.
Phase II/III Randomized Study of Conventional vs T cell Depleted Unrelated Donor Bone Marrow Transplantation for Leukemia, Myelodysplasia, and Lymphoblastic Lymphoma (Summary Last Modified 02/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
55 and under
NCI
MCV-CCHR-9504-2X
DUMC-75951, NCI-G98-1388, NCT00003187
Last Modified:
12/6/2007
 
First Published:
9/24/2003
4.
Phase II/III Randomized Study of Immunotherapy Comprising Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Patients With Refractory or Relapsed Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
Under 30
NCI
COG-AHOD0121
NCT00070187, AHOD0121
Last Modified:
7/11/2007
5.
Phase III Randomized Study of FK506 vs CYSP as GVHD Prophylaxis Following Allogeneic Bone Marrow Transplantation (Summary Last Modified 05/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
12 and over
WSU-Z-1093-93
NCI-V94-0363
Last Modified:
5/24/2006
6.
Phase III Randomized Study of Bone Marrow Transplantation vs Prolonged Intensive Chemotherapy Following Remission Re-Induction after Early First Marrow Relapse in Children with Acute Lymphocytic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
at least 1 + under 20 at diag.
NCI
CCG-1941
Last Modified:
5/16/2008
7.
Phase III Study of Treatment for Childhood Acute Myeloid Leukemia: High vs Standard Dose Cytarabine in the Daunorubicin, Cytarabine, Thioguanine Induction Regimen, Multidrug Resistance (MDR) Modulation with Cyclosporine vs No MDR Modulation During Consolidation, and a Comparison of Allogeneic Bone Marrow Transplant and Consolidative Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
under 21
NCI
POG-9421
Last Modified:
7/11/2007
8.
Phase III Randomized Study of FK506 vs CYSP as GVHD Prophylaxis Following Allogeneic Bone Marrow Transplantation (Summary Last Modified 05/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
12 and over
Other
FHCRC-949.00
NCI-V95-0776
Last Modified:
4/8/2005
9.
Phase III Randomized Study of Re-induction with Standard vs Sequential ADE (ARA-C/DNR/VP-16) with and without Cyclosporine in Refractory or Relapsed Acute Myelogenous Leukemia (Summary Last Modified 02/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
any age
MRC-LEUK-AML-R
EU-95037
Last Modified:
1/1/1998
10.
Phase III Randomized, Double-Blind Study of Autologous Bone Marrow Transplantation Alone or with Cyclosporine for Graft-Versus-Tumor Induction in Relapsed, Aggressive non-Hodgkin's Lymphoma (Summary Last Modified 01/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
2 to 65
Other
JHOC-9333
NCI-V96-0897
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute